Rectify Pharmaceuticals

Rectify Pharmaceuticals is a company developing disease-modifying precision therapies that restore ABC transporter function to address the underlying cause of serious genetic diseases. Its ABC transporters are a 48-member family of membrane-bound proteins with etiologic loss-of-function mutations in multiple organ systems and therapeutic areas including, the lungs, liver, gastrointestinal tract, eye, and central nervous system.